Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Breast Cancer Res Treat. 2020 Feb 15;180(3):747–757. doi: 10.1007/s10549-020-05572-y

Table 1:

Characteristics of the study sample

Breast cancer cases (n=3368)
N %
Demographics1
Age at cancer diagnosis
 65–69 840 24.9
 70–74 1035 30.7
 75–79 899 26.7
 ≥ 80 594 17.6
Race/ethnicity
 Non-Hispanic White 3045 90.4
 African American or Black 180 5.3
 Non-White/non-Black 143 4.2
Residence at diagnosis, percent urban
 0 154 4.8
 1–49 218 6.8
 50–99 614 19.2
 100 2210 69.1
Education
 High school diploma/GED or less 626 18.7
 School after high school 1232 36.8
 College degree or higher 1492 44.5
Body-mass index( kg/m2)
 <25 1109 33.2
 25 – <30 1147 34.3
 >=30 1087 32.5
Smoking status
 Never 1644 49.5
 Past 1516 45.7
 Current 158 4.8
Charlson comorbidity score3
 0 2482 73.7
 1 611 18.1
 2+ 275 8.2
Tumor characteristics
Summary Stage
 Localized 2669 79.2
 Regional 699 20.8
Tumor size (cm)
 ≤1 1358 40.3
 >1–2 1285 38.2
 >2–5 565 16.8
 >5 64 1.9
 Unknown 96 2.9
Nodal involvement
 No 2667 79.2
 Yes 662 19.7
 Unknown 39 1.2
ER receptor
 Positive 2787 82.7
 Negative 426 12.6
 Unknown 155 4.6
PR receptor
 Positive 2399 71.2
 Negative 795 23.6
 Unknown 174 5.2
Her2-neu receptor
 Positive 345 10.2
 Negative 2367 70.3
 Unknown 656 19.5
Triple negative
 No 3131 93.0
 Yes 237 7.0
Cancer treatment2
Chemotherapy
 No 2724 80.9
 Yes 644 19.1
Surgery type and radiation
 Breast-conserving with no radiation 361 10.7
 Breast conserving with radiation 1945 57.8
 Mastectomy with no radiation 852 25.3
 Mastectomy with radiation 210 6.2
1

Demographic characteristics as collected at enrollment in the Women’s Health Initiative, except as noted.

2

Derived from Medicare claims data